Autism and urinary exogenous neuropeptides: Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory

K. Dettmer, D. Hanna, P. Whetstone, Robin L Hansen, B. D. Hammock

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Autism is a complex neurodevelopmental disorder with unknown etiology. One hypothesis regarding etiology in autism is the "opioid peptide excess" theory that postulates that excessive amounts of exogenous opioid-like peptides derived from dietary proteins are detectable in urine and that these compounds may be pathophysiologically important in autism. A selective LC-MS/MS method was developed to analyze gliadinomorphin, β-casomorphin, deltorphin 1, and deltorphin 2 in urine. The method is based on on-line SPE extraction of the neuropeptides from urine, column switching, and subsequent HPLC analysis. A limit of detection of 0.25 ng/mL was achieved for all analytes. Analyte recovery rates from urine ranged between 78% and 94%, with relative standard deviations of 0.2-6.8%. The method was used to screen 69 urine samples from children with and without autism spectrum disorders for the occurrence of neuropeptides. The target neuropeptides were not detected above the detection limit in either sample set.

Original languageEnglish (US)
Pages (from-to)1643-1651
Number of pages9
JournalAnalytical and Bioanalytical Chemistry
Volume388
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Autistic Disorder
Tandem Mass Spectrometry
Neuropeptides
Opioid Analgesics
Mass spectrometry
High Pressure Liquid Chromatography
Urine
Opioid Peptides
Dietary Proteins
Limit of Detection
Recovery
Peptides
deltorphin

Keywords

  • β-Casomorphin
  • Autism
  • Gliadinomorphin
  • Neuropeptides
  • On-line SPE-HPLC-MS/MS
  • Opioid peptide excess theory

ASJC Scopus subject areas

  • Analytical Chemistry
  • Clinical Biochemistry

Cite this

Autism and urinary exogenous neuropeptides : Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. / Dettmer, K.; Hanna, D.; Whetstone, P.; Hansen, Robin L; Hammock, B. D.

In: Analytical and Bioanalytical Chemistry, Vol. 388, No. 8, 08.2007, p. 1643-1651.

Research output: Contribution to journalArticle

@article{df2ceaa96a794b59abdbd48c2c9b4ec7,
title = "Autism and urinary exogenous neuropeptides: Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory",
abstract = "Autism is a complex neurodevelopmental disorder with unknown etiology. One hypothesis regarding etiology in autism is the {"}opioid peptide excess{"} theory that postulates that excessive amounts of exogenous opioid-like peptides derived from dietary proteins are detectable in urine and that these compounds may be pathophysiologically important in autism. A selective LC-MS/MS method was developed to analyze gliadinomorphin, β-casomorphin, deltorphin 1, and deltorphin 2 in urine. The method is based on on-line SPE extraction of the neuropeptides from urine, column switching, and subsequent HPLC analysis. A limit of detection of 0.25 ng/mL was achieved for all analytes. Analyte recovery rates from urine ranged between 78{\%} and 94{\%}, with relative standard deviations of 0.2-6.8{\%}. The method was used to screen 69 urine samples from children with and without autism spectrum disorders for the occurrence of neuropeptides. The target neuropeptides were not detected above the detection limit in either sample set.",
keywords = "β-Casomorphin, Autism, Gliadinomorphin, Neuropeptides, On-line SPE-HPLC-MS/MS, Opioid peptide excess theory",
author = "K. Dettmer and D. Hanna and P. Whetstone and Hansen, {Robin L} and Hammock, {B. D.}",
year = "2007",
month = "8",
doi = "10.1007/s00216-007-1301-4",
language = "English (US)",
volume = "388",
pages = "1643--1651",
journal = "Fresenius Zeitschrift fur Analytische Chemie",
issn = "0016-1152",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Autism and urinary exogenous neuropeptides

T2 - Development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory

AU - Dettmer, K.

AU - Hanna, D.

AU - Whetstone, P.

AU - Hansen, Robin L

AU - Hammock, B. D.

PY - 2007/8

Y1 - 2007/8

N2 - Autism is a complex neurodevelopmental disorder with unknown etiology. One hypothesis regarding etiology in autism is the "opioid peptide excess" theory that postulates that excessive amounts of exogenous opioid-like peptides derived from dietary proteins are detectable in urine and that these compounds may be pathophysiologically important in autism. A selective LC-MS/MS method was developed to analyze gliadinomorphin, β-casomorphin, deltorphin 1, and deltorphin 2 in urine. The method is based on on-line SPE extraction of the neuropeptides from urine, column switching, and subsequent HPLC analysis. A limit of detection of 0.25 ng/mL was achieved for all analytes. Analyte recovery rates from urine ranged between 78% and 94%, with relative standard deviations of 0.2-6.8%. The method was used to screen 69 urine samples from children with and without autism spectrum disorders for the occurrence of neuropeptides. The target neuropeptides were not detected above the detection limit in either sample set.

AB - Autism is a complex neurodevelopmental disorder with unknown etiology. One hypothesis regarding etiology in autism is the "opioid peptide excess" theory that postulates that excessive amounts of exogenous opioid-like peptides derived from dietary proteins are detectable in urine and that these compounds may be pathophysiologically important in autism. A selective LC-MS/MS method was developed to analyze gliadinomorphin, β-casomorphin, deltorphin 1, and deltorphin 2 in urine. The method is based on on-line SPE extraction of the neuropeptides from urine, column switching, and subsequent HPLC analysis. A limit of detection of 0.25 ng/mL was achieved for all analytes. Analyte recovery rates from urine ranged between 78% and 94%, with relative standard deviations of 0.2-6.8%. The method was used to screen 69 urine samples from children with and without autism spectrum disorders for the occurrence of neuropeptides. The target neuropeptides were not detected above the detection limit in either sample set.

KW - β-Casomorphin

KW - Autism

KW - Gliadinomorphin

KW - Neuropeptides

KW - On-line SPE-HPLC-MS/MS

KW - Opioid peptide excess theory

UR - http://www.scopus.com/inward/record.url?scp=34547463516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547463516&partnerID=8YFLogxK

U2 - 10.1007/s00216-007-1301-4

DO - 10.1007/s00216-007-1301-4

M3 - Article

C2 - 17520243

AN - SCOPUS:34547463516

VL - 388

SP - 1643

EP - 1651

JO - Fresenius Zeitschrift fur Analytische Chemie

JF - Fresenius Zeitschrift fur Analytische Chemie

SN - 0016-1152

IS - 8

ER -